23/01/2025  17:35:56 Var. +1.040 Volume Denaro17:40:00 Lettera17:40:00 Capitalizzazione di mercato Dividend Y. Rapporto P/E
99.890EUR +1.05% 1.66 mill.
Fatturato: 165.71 mill.
99.820Quantità in denaro: 22 100.240Quantità in lettera: 125 125.22 bill.EUR 3.76% 23.18

Descrizione business

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Paul Hudson
Consiglio di amministrazione
François-Xavier Roger, Houman Ashrafian, Natalie Bickford, Olivier Charmeil, Brian Foard, Emmanuel Frenehard, Brendan O’Callaghan, Roy Papatheodorou, Madeleine Roach, Thomas Triomphe, Julie Van Ongevalle
Consiglio di sorveglianza
Frédéric Oudéa, Paul Hudson, Christophe Babule, Clotilde Delbos, Rachel Duan, Carole Ferrand, Lise Kingo, Patrick Kron, Wolfgang Laux, Barbara Lavernos, Fabienne Lecorvaisier, Anne-Françoise Nesmes, Gilles Schnepp, John Sundy, Ceng-Yann Tran, Emile Voest, Antoine Yver
 

Dati aziendali

Name: Sanofi S.A.
Indirizzo: 54, Rue La Boétie,F-75008 Paris
Telefono: +33-1-53-77-40-00
Fax: +33-1-53-77-43-03
E-mail: -
Internet: https://www.sanofi.com/
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 88.70%
Data dell'IPO: -

Rapporti con gli investitori

Name: Eva Schaefer-Jansen
IR telefono: +33-1-53-77-45-45
IR Fax: -
IR e-mail: investor.relations@sanofi.com

Company calendar

CW 5 | 30/01/2025 4th Quarter/Annual Report
CW 17 | 24/04/2025 Interim Report 1st Quarter/3 Months
CW 31 | 31/07/2025 Interim Report 2nd Quarter/6 Months
CW 43 | 24/10/2025 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Non-French institutional
 
66.20%
French institutional
 
11.20%
L'Oréal S.A.
 
9.40%
Altri
 
6.40%
Miscellaneous
 
3.60%
Employees
 
3.20%